Loading

Jecho Laboratories

March 02, 2026
Ballroom I C
Type: Company Presentation
Focus Area: Oncology
Jecho Laboratories is a clinical-stage company focusing in oncology across fusion proteins, ADCs, TCEs, and bsAbs.
Jecho Laboratories
Year Founded: 2013
Lead Product in Development: JL14002 - VEGF biosimilar, NDA anticipated 2026 JLM019 - CD80/PD-L1 fusion protein
Speakers
Sarah Johnson
Head, Global Business Development
Jecho Laboratories